Skip to Content

Quniupristin-Dalfopristin use while Breastfeeding

Medically reviewed by Drugs.com. Last updated on Jul 3, 2021.

Quniupristin-Dalfopristin Levels and Effects while Breastfeeding

Summary of Use during Lactation

Quinupristin and dalfopristin are relatively large molecules that are unlikely to be excreted into breastmilk in large amounts or to be absorbed orally by the breastfeeding infant.[1] However, since no information is available on the use of quinupristin and dalfopristin during breastfeeding, an alternate drug may be preferred, especially while nursing a newborn or preterm infant.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

References

1.
Chin KG, Mactal-Haaf C, McPherson CE III. Use of anti-infective agents during lactation: Part 1 -- beta-lactam antibiotics, vancomycin, quinupristin-dalfopristin, and linezolid. J Hum Lact. 2000;16:351–8. [PubMed: 11155614]

Substance Identification

Substance Name

Quniupristin-Dalfopristin

CAS Registry Number

126602-89-9

Drug Class

Breast Feeding

Lactation

Anti-Bacterial Agents

Anti-Infective Agents

Protein Synthesis Inhibitors

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.